DEEPIKA MATHIALAGAN: Open Payments
NPI 1730742594 · HERNDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 39 payments from 15 companies in 2025. Trend: 2023 $427 · 2024 $1,044 · 2025 $898
Food & beverage: $819Education: $79
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $189 |
| PFIZER INC. | 6 | $146 |
| Astellas Pharma US Inc | 2 | $107 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Lilly USA, LLC | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Hologic Sales and Service, LLC | 1 | $24 |
| Becton, Dickinson and Company | 1 | $23 |
Products named: NURTEC ODT, Ozempic, REXULTI, MOUNJARO, JARDIANCE, CAPLYTA, Wegovy, BREZTRI.
Industry payments across VA — which companies pay providers there.
